Thalassemia Market Analysis, Technical Study And Business Opportunities To 2031

The Global Thalassemia Market is a rapidly growing market that is valued at approximately USD 2.58 billion in 2021. Thalassemia is an inherited blood disorder characterized by a lack of hemoglobin production.

It can be well-managed with treatments such as blood transfusions and chelation therapy. The market is expected to experience a healthy growth rate of over 5% during the forecast period of 2022-2029.

Request To Download Sample of This Strategic Report:- https://reportocean.com/industry-verticals/sample-request?report_id=bw7217

The increasing prevalence of blood disorders, including thalassemia, is a key factor driving the market growth. For example, India has a significant number of thalassemia-affected children and carriers, accounting for approximately 10% of the world incidence. Beta-thalassemia affects 2.9% of the world's population.

The growing healthcare industry in developing regions and an increasing number of clinical trials for blood disorders also contribute to the market's growth prospects.

However, the high cost associated with thalassemia treatment acts as a restraint for market growth throughout the forecast period.

In terms of regional analysis, North America dominates the market due to the growing incidences of thalassemia and increased investment in health infrastructure. On the other hand, Asia Pacific is expected to exhibit the highest growth rate during the forecast period.

This growth can be attributed to factors such as a rising geriatric population, growing incidences of blood-related disorders, and the rapid expansion of contract manufacturing organizations in the region.

Some of the major players in the Global Thalassemia Market include Bluebird Bio Inc., Acceleron Pharma, Inc., Celgene Corporation, GlaxoSmithKline plc, Incyte Corporation, Gamida Cell, Kiadis Pharma, La Jolla Pharmaceutical Company, IONIS Pharmaceuticals, and Novartis AG.

Download Free Sample of This Strategic Report:- https://reportocean.com/industry-verticals/sample-request?report_id=bw7217

A recent development in the market is the approval of Zynteglo (betibeglogene autotemcel) by the U.S. Food and Drug Administration in August 2022. Zynteglo is the first cell-based gene therapy intended for the treatment of adult and pediatric patients affected by beta-thalassemia.

The report provides a comprehensive scope of the market, including historical data from 2019-2021 and forecasts for the period of 2022-2029. It covers various segments such as therapeutic class (iron chelating drugs) and pipeline (gene therapy). The regional scope includes North America, Europe, Asia Pacific, Latin America, and the Rest of the World.

The objective of the study is to define the market size of different segments and countries and forecast their values for the coming years. The report incorporates both qualitative and quantitative aspects of the industry and provides detailed information about driving factors, challenges, opportunities, competitive landscape, and product offerings of key players.

Please note that the information provided is a summary of the Global Thalassemia Market report and does not represent the full content of the report.

The global Smart market report answers questions such as:

• What is the market size and forecast of the Global Smart airport Market?
• What are the inhibiting factors and impact of COVID-19 on the Global Smart airport Market during the assessment period?
• Which are the products/segments/applications/areas to invest in over the assessment period in the Global Smart airport Market?
• What is the competitive strategic window for opportunities in the Global Smart airport Market?
• What are the technology trends and regulatory frameworks in the Global Smart airport Market?
• What is the market share of the leading players in the Global Smart airport Market?
• What modes and strategic moves are considered favorable for entering the Global Smart airport Market?

Request Full Report -https://reportocean.com/industry-verticals/sample-request?report_id=bw7217

About Report Ocean:

We are the best market research reports provider in the industry. Report Ocean is the world's leading research company, known for its informative research reports. We are committed to providing our clients with both quantitative and qualitative research results. As a part of our global network and comprehensive industry coverage, we offer in-depth knowledge, allowing informed and strategic business conclusions to report. We utilize the most recent technology and analysis tools along with our own unique research models and years of expertise, which assist us to create necessary details and facts that exceed expectations.

Get in Touch with Us:
Report Ocean:
Email: sales@reportocean.com
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 - UNITED STATES
Tel:+1 888 212 3539 (US - TOLL FREE)
Website: https://reportocean.com

This release was published on openPR.